Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?
about
Using "Omics" and Integrated Multi-Omics Approaches to Guide Probiotic Selection to Mitigate Chytridiomycosis and Other Emerging Infectious DiseasesAdaptation to Lactose in Lactase Non Persistent People: Effects on Intolerance and the Relationship between Dairy Food Consumption and Evalution of DiseasesNew insights into therapeutic strategies for gut microbiota modulation in inflammatory diseasesThe human neonatal gut microbiome: a brief reviewDynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity.One size will never fit all: the future of research in pediatric transfusion medicine.Intestinal microbiota and its relationship with necrotizing enterocolitis.Effects of Fuzhuan Brick-Tea Water Extract on Mice Infected with E. coli O157:H7.Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population.Lactobacillus reuteri and Staphylococcus aureus differentially influence the generation of monocyte-derived dendritic cells and subsequent autologous T cell responses.Diet and nutrition in cancer survivorship and palliative care.Lactobacillus rhamnosus GG supernatant enhance neonatal resistance to systemic Escherichia coli K1 infection by accelerating development of intestinal defenseLactoferrin and neonatology - role in neonatal sepsis and necrotizing enterocolitis: present, past and future.Impact of probiotics on necrotizing enterocolitis.Microbial therapeutic interventions.Effect of bacteriocin and exopolysaccharides isolated from probiotic on P. aeruginosa PAO1 biofilm.Lactobacillus fermentum Postbiotic-induced Autophagy as Potential Approach for Treatment of Acetaminophen Hepatotoxicity.Probiotics and necrotizing enterocolitis.Routine Supplementation of Lactobacillus rhamnosus GG and Risk of Necrotizing Enterocolitis in Very Low Birth Weight Infants.Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation.Biomarkers of necrotizing enterocolitis: a review of literature.Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.A Controlled Fermented Samjunghwan Herbal Formula Ameliorates Non-alcoholic Hepatosteatosis in HepG2 Cells and OLETF Rats.In vitro and in vivo defensive effect of probiotic LAB against Pseudomonas aeruginosa using Caenorhabditis elegans modelImmunomodulatory Effects of Probiotics on Cytokine Profiles
P2860
Q26766432-29D02275-ED30-4F6C-8244-F65BC883621AQ26796616-6DB9BC45-B13E-448C-B7BE-41285D40A4B8Q28079638-6A40691A-824D-441E-B43A-9794AE0AE082Q28080685-4AD027D9-D9F3-4889-B10A-325191EA36C3Q35069368-B04FDD8F-9386-4B61-A548-7F25AFC5A6F1Q35535157-00EBB206-EF95-4AAF-8145-723F4B3CDC72Q35636352-28C60E1A-4D44-4C08-BD37-1A125ED78207Q35682224-C0527051-0A68-44E8-ABDA-BE1AB9AEEB19Q36014389-CDD7D99A-9BC3-4B50-AB4B-AECAA6F9C890Q37216050-9CFA170A-AC46-462D-9F58-F2DA500FC776Q37322307-81198B96-95B5-4B6E-8D2C-9C0838C44BD4Q37681849-BC85405C-6B11-4F98-B131-2F2F35BA7D3AQ38372967-58303788-A284-4F7B-9F4C-ED70F46CAA0CQ38796288-18C99548-6E37-42A9-821E-A942765809F9Q38822502-92A0797E-E98A-462E-ACF4-7D622448E6B0Q40047173-DF91F498-066E-416C-819C-08F5FE859425Q42120606-FAEA95AB-B0D6-4E96-8EAA-026F553C0D40Q47252497-1F1DB2D3-D2F7-4374-8ADB-7AD850147D1DQ52699279-4BFA402A-E4A0-4DC5-BC23-DCA28EBC939AQ52725765-8EBB2FA1-181D-490D-88C2-B9DEE8F94C6FQ54782705-A663D339-8E69-4D32-BF49-30EEC7801877Q55040688-33DA3CC1-920C-4368-AB30-43F522FCCF02Q55512003-7B15D0CF-4E2B-4BB1-9ECA-158A711D559CQ58693953-E3DEABFC-FE07-4DD5-B90D-A3FE6A45B018Q58697876-8DEACF5F-AE5C-4342-B598-4B62E54F1FD2
P2860
Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Therapeutic use of prebiotics, ...... what is the current evidence?
@ast
Therapeutic use of prebiotics, ...... what is the current evidence?
@en
type
label
Therapeutic use of prebiotics, ...... what is the current evidence?
@ast
Therapeutic use of prebiotics, ...... what is the current evidence?
@en
prefLabel
Therapeutic use of prebiotics, ...... what is the current evidence?
@ast
Therapeutic use of prebiotics, ...... what is the current evidence?
@en
P2860
P1476
Therapeutic use of prebiotics, ...... what is the current evidence?
@en
P2093
Patricia Wei Denning
P2860
P356
10.1016/J.CLP.2012.12.002
P577
2013-01-17T00:00:00Z